Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-7991

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-7991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole Fig1)

A line graph showing percent maintained over months for Esomeprazole Magnesium in 40 mg, 20 mg, and 10 mg doses compared with placebo. The x-axis represents months with scheduled visits marked, and the y-axis shows percent maintained from 0 to 100%. The 40 mg dose maintains the highest percent, followed by 20 mg, 10 mg, and placebo declining over 6 months.*

FDA Label Image

Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole Fig2)

A line graph showing percent maintained over a 6-month period with scheduled visits marked. The graph compares Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and placebo groups, illustrating treatment efficacy over time with the 40 mg dose maintaining the highest percentage.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

A line graph depicting the percentage of patients symptom-free over 28 diary days, comparing Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The y-axis shows percent of patients symptom-free, and the x-axis shows diary days from 0 to 28. Both Esomeprazole groups show higher symptom-free rates than placebo over time.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

A line graph depicting the percent of patients symptom-free over 28 diary days comparing Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg strengths versus placebo. The vertical axis shows the percent of patients symptom-free, and the horizontal axis shows diary days from 0 to 28. Data points indicate higher symptom-free percentages for both dosages of Esomeprazole Magnesium compared to placebo throughout the study period.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical structure of Esomeprazole Magnesium, showing the molecular arrangement including two Esomeprazole molecules complexed with Mg2+ ion and associated with three water molecules (3 H2O). The structure includes methoxy groups, methyl groups, and sulfoxide functional groups.*

FDA Label Image

Label Image (Lbl500907991)

Label for Esomeprazole Magnesium delayed-release capsules, 40 mg strength, packaged in a container of 30 capsules. The label includes dosage instructions advising medication be taken at least one hour before meals. The product is labeled as prescription only and manufactured by A-S Medication Solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.